Jessica E Rothman
Overview
Explore the profile of Jessica E Rothman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrone M, Rothman J, Breban M, Ott I, Russell A, Lasek-Nesselquist E, et al.
Commun Biol
. 2022 May;
5(1):439.
PMID: 35545661
SARS-CoV-2 variants shaped the second year of the COVID-19 pandemic and the discourse around effective control measures. Evaluating the threat posed by a new variant is essential for adapting response...
2.
Earnest R, Uddin R, Matluk N, Renzette N, Turbett S, Siddle K, et al.
Cell Rep Med
. 2022 Apr;
3(4):100583.
PMID: 35480627
The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an estimated 40%-80% increased transmissibility over Alpha. To investigate if this ostensible difference in transmissibility is uniform across...
3.
Allicock O, Petrone M, Yolda-Carr D, Breban M, Walsh H, Watkins A, et al.
BMC Infect Dis
. 2022 Mar;
22(1):284.
PMID: 35337266
Background: There is an urgent need to expand testing for SARS-CoV-2 and other respiratory pathogens as the global community struggles to control the COVID-19 pandemic. Current diagnostic methods can be...
4.
Earnest R, Uddin R, Matluk N, Renzette N, Siddle K, Loreth C, et al.
medRxiv
. 2021 Oct;
PMID: 34642698
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant quickly rose to dominance in mid-2021, displacing other variants, including Alpha. Studies using data from the United Kingdom and India...
5.
Lucas C, Vogels C, Yildirim I, Rothman J, Lu P, Monteiro V, et al.
Nature
. 2021 Oct;
600(7889):523-529.
PMID: 34634791
The emergence of SARS-CoV-2 variants with mutations in major neutralizing antibody-binding sites can affect humoral immunity induced by infection or vaccination. Here we analysed the development of anti-SARS-CoV-2 antibody and...
6.
Rothman J, Eidelberg D, Rothman S, Holford T, Rothman D
PLoS One
. 2021 Aug;
16(8):e0253843.
PMID: 34407073
Background: Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had...
7.
Petrone M, Rothman J, Breban M, Ott I, Russell A, Lasek-Nesselquist E, et al.
medRxiv
. 2021 Jul;
PMID: 34230938
Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new...
8.
Vogels C, Breban M, Ott I, Alpert T, Petrone M, Watkins A, et al.
PLoS Biol
. 2021 May;
19(5):e3001236.
PMID: 33961632
With the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants that may increase transmissibility and/or cause escape from immune responses, there is an urgent need for the targeted...
9.
Allicock O, Petrone M, Yolda-Carr D, Breban M, Walsh H, Watkins A, et al.
medRxiv
. 2021 Feb;
PMID: 33564787
There is an urgent need to expand testing for SARS-CoV-2 and other respiratory pathogens as the global community struggles to control the COVID-19 pandemic. Current diagnostic methods can be affected...